Elizabeth A Evans1, Sarah L Goff2, Dawn M Upchurch3, Christine E Grella4. 1. Department of Health Promotion and Policy, School of Public Health and Health Sciences, University of Massachusetts Amherst, MA, USA. Electronic address: eaevans@umass.edu. 2. Department of Health Promotion and Policy, School of Public Health and Health Sciences, University of Massachusetts Amherst, MA, USA. 3. Department of Community Health Sciences, UCLA Fielding School of Public Health, Los Angeles, CA, USA. 4. UCLA Integrated Substance Abuse Programs, Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA, USA.
Abstract
INTRODUCTION: To examine gender differences in associations between mental health comorbidity and adverse childhood experiences (ACE) among adults with DSM-5 lifetime opioid use disorders (OUD). METHODS: In 2018, we analyzed 2012-13 nationally-representative data from 388 women and 390 men with OUD (heroin, prescription opioid misuse). Using weighted multinomial logistic regression, we examined factors associated with mental health comorbidity, tested a gender-by-childhood-adversity interaction term, and calculated predicted probabilities, controlling for covariates. RESULTS: Among adults with OUD, women are more likely than men to have comorbid mood or anxiety disorders (odds ratio [95% CI] 1.72 [1.20, 2.48]), and less likely to have conduct disorders. More women than men have prescription OUD (3.72 [2.24, 6.17]), and fewer have heroin use disorder (0.39 [0.27, 0.57]). Among both genders, ACE prevalence is high (>80%) and more than 40% are exposed to ≥3 types of ACE. Women more than men are exposed to childhood sexual abuse (4.22 [2.72, 6.56]) and emotional neglect (1.84 [1.20, 2.81]). Comorbid mood or anxiety disorders are associated with female gender (1.73 [1.18, 2.55]) and exposure to ≥3 types of ACE (3.71 [2.02, 6.85]), controlling for covariates. Moreover, exposure to more ACE elevates risk for comorbid mood or anxiety disorders more among women than men. CONCLUSION: Among adults with OUD, ACE alters the gender gap in risk for comorbid mood or anxiety disorders. Using gender-tailored methods to address the harmful effects ACE on the mental health of individuals with OUD may help to prevent and ameliorate the current opioid epidemic.
INTRODUCTION: To examine gender differences in associations between mental health comorbidity and adverse childhood experiences (ACE) among adults with DSM-5 lifetime opioid use disorders (OUD). METHODS: In 2018, we analyzed 2012-13 nationally-representative data from 388 women and 390 men with OUD (heroin, prescription opioid misuse). Using weighted multinomial logistic regression, we examined factors associated with mental health comorbidity, tested a gender-by-childhood-adversity interaction term, and calculated predicted probabilities, controlling for covariates. RESULTS: Among adults with OUD, women are more likely than men to have comorbid mood or anxiety disorders (odds ratio [95% CI] 1.72 [1.20, 2.48]), and less likely to have conduct disorders. More women than men have prescription OUD (3.72 [2.24, 6.17]), and fewer have heroin use disorder (0.39 [0.27, 0.57]). Among both genders, ACE prevalence is high (>80%) and more than 40% are exposed to ≥3 types of ACE. Women more than men are exposed to childhood sexual abuse (4.22 [2.72, 6.56]) and emotional neglect (1.84 [1.20, 2.81]). Comorbid mood or anxiety disorders are associated with female gender (1.73 [1.18, 2.55]) and exposure to ≥3 types of ACE (3.71 [2.02, 6.85]), controlling for covariates. Moreover, exposure to more ACE elevates risk for comorbid mood or anxiety disorders more among women than men. CONCLUSION: Among adults with OUD, ACE alters the gender gap in risk for comorbid mood or anxiety disorders. Using gender-tailored methods to address the harmful effects ACE on the mental health of individuals with OUD may help to prevent and ameliorate the current opioid epidemic.
Keywords:
Adverse childhood experiences (ACE); DSM-5 comorbid mood and anxiety disorders; DSM-5 opioid use disorder; Gender differences; National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III)
Authors: Deborah S Hasin; Dvora Shmulewitz; Malka Stohl; Eliana Greenstein; Christina Aivadyan; Kara Morita; Tulshi Saha; Efrat Aharonovich; Jeesun Jung; Haitao Zhang; Edward V Nunes; Bridget F Grant Journal: Drug Alcohol Depend Date: 2015-04-06 Impact factor: 4.492
Authors: Jennifer Greif Green; Katie A McLaughlin; Patricia A Berglund; Michael J Gruber; Nancy A Sampson; Alan M Zaslavsky; Ronald C Kessler Journal: Arch Gen Psychiatry Date: 2010-02
Authors: Elizabeth A Evans; Dawn M Upchurch; Tracy Simpson; Alison B Hamilton; Katherine J Hoggatt Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2017-11-29 Impact factor: 4.519
Authors: Robert F Anda; Maxia Dong; David W Brown; Vincent J Felitti; Wayne H Giles; Geraldine S Perry; Edwards J Valerie; Shanta R Dube Journal: BMC Public Health Date: 2009-04-16 Impact factor: 3.295
Authors: Tiffany Love; Andrey A Shabalin; Rachel L Kember; Anna R Docherty; Hang Zhou; Vincent Koppelmans; Joel Gelernter; Anne K Baker; Emily Hartwell; Jacob Dubroff; Jon-Kar Zubieta; Henry R Kranzler Journal: Neuropsychopharmacology Date: 2022-05-11 Impact factor: 8.294
Authors: Alice Fiddian-Green; Aline Gubrium; Calla Harrington; Elizabeth A Evans Journal: Int J Environ Res Public Health Date: 2022-07-30 Impact factor: 4.614
Authors: Jessica C Smith; Leigh Alderman; Brandon K Attell; Wendy Avila Rodriguez; Jana Covington; Brigitte Manteuffel; Ann M DiGirolamo; Susan M Snyder; Karen Minyard Journal: Front Psychol Date: 2021-06-29